-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
2seventy bio, Inc. quarterly/annual Revenues history and change rate from 2019 to Q1 2025.
- 2seventy bio, Inc. Revenues for the quarter ending 31 Mar 2025 was $22.9M, a 84.5% increase year-over-year.
- 2seventy bio, Inc. Revenues for the twelve months ending 31 Mar 2025 was $48.4M, a 32.1% decline year-over-year.
- 2seventy bio, Inc. annual Revenues for 2024 was $37.9M, a 62.3% decline from 2023.
- 2seventy bio, Inc. annual Revenues for 2023 was $100M, a 9.72% increase from 2022.
- 2seventy bio, Inc. annual Revenues for 2022 was $91.5M, a 67.8% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)